When Gale Wild-Ebers, 62, ordered a second tube of Incyte’s topical eczema drug Opzelura in March, something appeared wrong with the product she received. Instead …
By now, it’s no surprise that the global pandemic has worsened long-standing health inequities—and pharma has stepped up with a flood of initiatives to try …
Drug development is an expensive, lengthy, and high-risk business taking 1015 years and is associated with a high attrition rate. Approximately only 1 in 10 …
Researchers from Samsung Medical Center and Guardant Health, Inc. have demonstrated the feasibility of determining a measure analogous to tumor mutation burden (TMB), a promising …
The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has achieved a milestone with the …
The debate is surging days before the results of a large clinical trial are to be unveiled this week Sweeping clinical trials in which thousands …
Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with uncontrolled …
NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced today that it is launching …
Singapore – Researchers at Northwell Health’s Feinstein Institute for Medical Research are conducting a clinical trial to evaluate the efficacy of bioelectronic medicine to treat pain associated …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
